Showing 2161-2170 of 2527 results for "".
- EyePoint Pharmaceuticals and ImprimisRx Announce U.S. Commercial Alliance for Dexycuhttps://modernod.com/news/eyepoint-pharmaceuticals-and-imprimisrx-announce-u-s-commercial-alliance-for-dexycu/2478119/EyePoint Pharmaceuticals and ImprimisRx announced the signing of a commercial alliance for the joint promotion of Dexycu (dexamethasone intraocular suspension) 9% for the treatment of postoperative inflammation following ocular surgery in the United States.
- The Vision Council Releases 2019 Vision Watch Cataract Reporthttps://modernod.com/news/the-vision-council-releases-2019-vision-watch-cataract-report/2478110/The Vision Council recently released the results of the 2019 VisionWatch Cataract Report. Conducted in December 2019, the study measures changes in consumer behavior related to vision and vision correction after undergoing cataract surgery. The intent of the study was to explore how cataract surg
- AAO: ACA’s Medicaid Expansion Failed to Improve Diabetic Dilated Eye Exam Rates Long-Termhttps://modernod.com/news/aao-acas-medicaid-expansion-failed-to-improve-diabetic-dilated-eye-exam-rates-long-term/2478111/New research shows significantly more people with diabetes got their critical annual dilated eye exam during the first 2 years following Medicaid expansion under the under the Affordable Care Act (ACA). However, this encouraging increase in the exam rate did not persist beyond 2 years. The study’
- How COVID-19 Causes Smell Losshttps://modernod.com/news/how-covid-19-causes-smell-loss/2478103/Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19. Studies suggest it better predicts the disease than other well-known symptoms such as fever and cough, but the underlying mechan
- 4D Molecular Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of 4D-110 by Intravitreal Injection for the Treatment of Choroideremiahttps://modernod.com/news/4d-molecular-therapeutics-announces-first-patient-dosed-in-phase-1-clinical-trial-of-4d-110-by-intravitreal-injection-for-the-treatment-of-choroideremia/2478092/4D Molecular Therapeutics (4DMT) announced that the first patient has been dosed in the phase 1 clinical trial of 4D-110, a Roche-licensed product candidate, delivered by a single intravitreal injection for Choroideremia. Choroideremia is a blinding and currently untreatable X-linked inher
- Bascom Palmer Eye Institute Ranked Nation’s No. 1 in Ophthalmology for 19th Timehttps://modernod.com/news/bascom-palmer-eye-institute-ranked-nations-no-1-in-ophthalmology-for-19th-time/2478089/Bascom Palmer Eye Institute of the University of Miami Health System has been ranked again as the nation’s best in ophthalmology by U.S News & World Report. This year marks the 19th time, and the 17th consecutive year, that
- AcuFocus Announces Extended Diopter Range for the IC-8 Small Aperture IOLhttps://modernod.com/news/acufocus-announces-extended-diopter-range-for-the-ic-8-small-aperture-iol/2478087/AcuFocus announced that the IC-8 small aperture IOL power range now extends from +10.0 D to +30.0 D (0.50 D steps), offering eye care physicians the opportunity to provide more patients an uninterrupted extended range
- Algorithm Compares Risk of Cancelled Ophthalmology Appointments Against COVID-19https://modernod.com/news/algorithm-compares-risk-of-cancelled-ophthalmology-appointments-against-covid-19/2478075/The COVID-19 pandemic has forced many ophthalmologists across the US to cancel potentially necessary eye examinations with patients since March. A team, led by Nikhil K. Bommakanti, MD, W.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, developed a f
- Novartis Launches “Not Today, Dry Eye” Consumer Campaignhttps://modernod.com/news/novartis-launches-not-today-dry-eye-consumer-campaign/2478073/This month, Novartis launched its new direct-to-consumer commercial and campaign “Not Today, Dry Eye,” which aims to improve awareness of dry eye disease (DED) among consumers. This campaign underscores the fact that inflammation can play an important role in the development and amplification of
- Pepcid As a Coronavirus Remedy? Trump’s $21-Million Gamble Fizzledhttps://modernod.com/news/pepcid-as-a-coronavirus-remedy-trumps-21-million-gamble-fizzled/2478070/As the coronavirus began its deadly march through the world, two well-respected American doctors identified a possible but seemingly unlikely remedy: Pepcid, the heartburn medication found on drugstore shelves everywhere, according to an Associated